Virdante Pharmaceuticals

Virdante Pharmaceuticals

Developing a proprietary “sialic switch” technology to improve the anti-inflammatory properties of intravenous immunoglobulin (IVIG) antibodies. Virdante Pharmaceuticals was spun out of Rockefeller University.

Acquired by Momenta Pharmaceuticals

Virdante-header